1-10 of 10
Takeshi Kotake
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P2-26-07: Alteration of gut microbiota signatures and its association with diarrhea during abemaciclib treatment: A multicenter prospective cohort study (KBCRN-A002 study)

Kosuke Kawaguchi, Yurina Maeshima, Hiroshi Ishiguro, Kazuhiko Yamagami, Sachiko Takahara, Hirofumi Suwa, Masae Torii, Shigenori Nagai, Yasuaki Sagara, Wakako Tsuji, Hiroyasu Yamashiro, Takeshi Kotake, Shinji Fukuda, Kuniaki Saito, Yasuko Yamamoto, Masako Kataoka, Yuki Himoto, Atsushi Yonezawa, Yukiko Fukui, Yuki Nakamura, Wei Li, Sunao Tanaka, Satoshi Morita, Masakazu Toi
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-26-07.
https://doi.org/10.1158/1538-7445.SABCS22-P2-26-07
Published: 01 March 2023
View article titled, Abstract P2-26-07: Alteration of gut microbiota signatures and its association with diarrhea during abemaciclib treatment: A multicenter prospective cohort study (KBCRN-A002 study)
Journal Articles

Abstract 6161: HER3 expression is associated with cold tumor immune microenvironment and the regulation of its signal in humanized breast cancer patient derived xenograft models converts to hot tumor

Sunao Tanaka, Eiji Suzuki, Takeshi Kotake, Shinpei Kawaoka, Kosuke Kawaguchi, Tomomi Nishimura, Fengling Pu, Masakazu Toi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6161.
https://doi.org/10.1158/1538-7445.AM2022-6161
Published: 15 June 2022
View article titled, Abstract 6161: HER3 expression is associated with cold tumor immune microenvironment and the regulation of its signal in humanized breast cancer patient derived xenograft models converts to hot tumor
Journal Articles

Pronociceptive Roles of Schwann Cell–Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy

Madoka Koyanagi, Satoshi Imai, Mayuna Matsumoto, Yoko Iguma, Nobuko Kawaguchi-Sakita, Takeshi Kotake, Yuki Iwamitsu, Mpumelelo Ntogwa, Ren Hiraiwa, Kazuki Nagayasu, Mamiko Saigo, Takashi Ogihara, Atsushi Yonezawa, Tomohiro Omura, Shunsaku Nakagawa, Takayuki Nakagawa, Kazuo Matsubara
Journal: Cancer Research
Cancer Res (2021) 81 (8): 2207–2219.
https://doi.org/10.1158/0008-5472.CAN-20-2799
Published: 15 April 2021
View article titled, Pronociceptive Roles of Schwann Cell–Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy
Open the PDF for Pronociceptive Roles of Schwann Cell–Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy in another window
Includes: Supplementary data
Journal Articles

Abstract PS13-31: Prospective observational study to explore the effectiveness of eribulin as first- or second- line chemotherapy in patients with HER2-negative hormone-resistant advanced or metastatic breast cancer (KBCRN A001: E-SPEC study)

Yuri Fujimoto, Yuichiro Kikawa, Takeshi Kotake, Shigeru Tsuyuki, Sachiko Takahara, Hiroyasu Yamashiro, Hiroshi Yoshibayashi, Masahiro Takada, Rie Yasuoka, Kazuhiko Yamagami, Hirofumi Suwa, Toshitaka Okuno, Ichiro Nakayama, Tatsuji Kato, Nobuko Ogura, Yoshio Moriguchi, Hiroshi Ishiguro, Tatsuo Kagimura, Tetsuya Taguchi, Tomoharu Sugie, Masakazu Toi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS13-31.
https://doi.org/10.1158/1538-7445.SABCS20-PS13-31
Published: 15 February 2021
View article titled, Abstract PS13-31: Prospective observational study to explore the effectiveness of eribulin as first- or second- line chemotherapy in patients with HER2-negative hormone-resistant advanced or metastatic breast cancer (KBCRN A001: E-SPEC study)
Journal Articles

Abstract P4-10-33: Alteration of the tumor immune microenvironment signatures by nivolumab combined with radiation therapy for patients with metastatic breast cancer (Translational Research of the KBCRN-B-002 trial)

Kosuke Kawaguchi, Masahiro Takada, Takeshi Kotake, Michio Yoshimura, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Laxmi Parida, Satoshi Morita, Masakazu Toi
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-10-33.
https://doi.org/10.1158/1538-7445.SABCS19-P4-10-33
Published: 15 February 2020
View article titled, Abstract P4-10-33: Alteration of the tumor immune microenvironment signatures by nivolumab combined with radiation therapy for patients with metastatic breast cancer (Translational Research of the KBCRN-B-002 trial)
Journal Articles

Abstract P3-09-07: A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial)

Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Laxmi Parida, Satoshi Morita, Masakazu Toi
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-09-07.
https://doi.org/10.1158/1538-7445.SABCS19-P3-09-07
Published: 15 February 2020
View article titled, Abstract P3-09-07: A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial)
Journal Articles

Abstract 2120: Human epidermal growth factor receptor 3 might be a targetable molecule for treatment of chemotherapy resistant breast cancer

Takeshi Kotake, Eiji Suzuki, Fengling Pu, Tatsuki Kataoka, Masahiro Hirata, Eri Hohokabe, Masakazu Toi
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2120.
https://doi.org/10.1158/1538-7445.AM2019-2120
Published: 01 July 2019
View article titled, Abstract 2120: Human epidermal growth factor receptor 3 might be a targetable molecule for treatment of chemotherapy resistant breast cancer
Journal Articles

Abstract 4151: Down regulation of ATP6V1B1 in HER2+ breast cancer leads resistance against trastuzumab mediated antibody dependent cellular cytotoxicity and it might be associated with less efficacy of trastuzumab clinically

Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Takeshi Kotake, Masahiro Hirata, Fengling Pu, Keiko Sakamoto, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4151.
https://doi.org/10.1158/1538-7445.AM2017-4151
Published: 01 July 2017
View article titled, Abstract 4151: Down regulation of ATP6V1B1 in HER2+ breast cancer leads resistance against trastuzumab mediated antibody dependent cellular cytotoxicity and it might be associated with less efficacy of trastuzumab clinically
Journal Articles

Abstract 5706: Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may be contribute to the identification and the immunological classification of breast cancer patients by blood test

Eiji Suzuki, Kosuke Kawaguchi, Masahiro Sugimoto, Fengling Pu, Ryuji Uozumi, Ayane Yamaguchi, Mariko Nishie, Moe Tsuda, Takeshi Kotake, Satoshi Morita, Masakazu Toi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5706.
https://doi.org/10.1158/1538-7445.AM2017-5706
Published: 01 July 2017
View article titled, Abstract 5706: Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may be contribute to the identification and the immunological classification of breast cancer patients by blood test
Journal Articles

Abstract 3697: The impact of HER3 signaling mediated PD-L1 regulation in triple negative breast cancer

Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Takeshi Kotake, Masakazu Toi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3697.
https://doi.org/10.1158/1538-7445.AM2017-3697
Published: 01 July 2017
View article titled, Abstract 3697: The impact of HER3 signaling mediated PD-L1 regulation in triple negative breast cancer